Drug profile · INN
nalmefene
SELINCRO
nalmefene (SELINCRO) is a kappa opioid receptor partial agonist.
EMA: approved Nervous system (N07) N07BB05
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — nalmefene
- Class
- Nervous system (N07)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
nalmefene (SELINCRO) is a kappa opioid receptor partial agonist.
Key facts
INN nalmefene
Brand SELINCRO
Mechanism Kappa opioid receptor partial agonist
Therapeutic class Nervous system (N07)
ATC code N07BB05
Mechanism of action
Kappa opioid receptor partial agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is nalmefene?
nalmefene (SELINCRO) is a kappa opioid receptor partial agonist.
What is the brand name for nalmefene?
SELINCRO is a marketed brand name for nalmefene. Check FDA Drugs@FDA for the current US label holder and prescribing information.